“…Researchers have ingeniously crafted a diverse array of such compounds through a series of spirocyclization reactions, such as [2+1], [4] [2+2], [5] [3+2], [6] [3+3], [7] and [4+3] [8] cyclization protocols, from which a number of molecules with potential therapeutic applications have been identified. Yet, the literature on spirooxindole structures predominantly documented mono‐spiro systems, [1,9] with a relative scarcity of reports on their bis‐spiro counterparts [4a,6,10] . Given the intriguing antitumor [11] and antitubercular [10b] activities exhibited by bisspiro(oxindole) structures (Figure 1), the paucity of synthetic reports for these molecules poses a significant obstacle to further biological exploration.…”